The effect of static magnetic fields and tat peptides on cellular and nuclear uptake of magnetic nanoparticles

Biomaterials

Volumn 31, Issue 15, 2010, Pages 4392-4400

  Smith, Carol Anne M ^a   Fuente, Jesus de la ^b   Pelaz, Beatriz ^b   Furlani, Edward P ^c   Mullin, Margaret ^a   Berry, Catherine C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Instituto de Nanociencia y Materiales de Aragón   (Spain)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Endocytosis; Fibroblast; Magnetism; Microarray; Nanoparticles; Tat peptide

Indexed keywords

BIOAPPLICATIONS; CAVEOLIN; CELL HOMEOSTASIS; CELL RESPONSE; CELL TRANSFECTION; CELL-PENETRATING PEPTIDE; CONTROL-CELL; ENDOCYTOSIS; ENHANCED UPTAKE; EXTERNAL MAGNETIC FIELD; F-ACTIN; GENE LEVELS; MAGNETIC FORCE; MAGNETIC NANOPARTICLES; MAGNETOFECTION; MICROARRAY ANALYSIS; NUCLEAR MEMBRANES; STATIC FIELDS; STATIC MAGNETIC FIELDS; TARGETED DELIVERY; TAT PEPTIDE;

CELL CULTURE; CELL MEMBRANES; FIBROBLASTS; GENE EXPRESSION; MAGNETIC FIELDS; MAGNETIC MATERIALS; NANOPARTICLES; NUCLEIC ACIDS; PEPTIDES; PLANTS (BOTANY);

NANOMAGNETICS;

CELL PENETRATING PEPTIDE; F ACTIN; NANOPARTICLE; TAT PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; CELL STRUCTURE; CELL TRANSPORT; CONTROLLED STUDY; FORCE; GENE; GENE EXPRESSION; GENETIC TRANSFECTION; HOMEOSTASIS; HUMAN; HUMAN CELL; MAGNETIC FIELD; MAGNETISM; MICROARRAY ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

CAVEOLINS; CELL LINE; CLATHRIN; CYTOSKELETON; ENDOCYTOSIS; FIBROBLASTS; GENE EXPRESSION; HUMANS; MAGNETICS; MATERIALS TESTING; METAL NANOPARTICLES; MICROARRAY ANALYSIS; PEPTIDES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77949657067     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.01.096     Document Type: Article

References (49)

1. Berry C.C., Curtis A.S.G. Functionalisation of magnetic nanoparticles for applications in biomedicine. J Phys D App Phys 2003, 36:R198-R206.
2. Kamei K., Mukai Y., Kojima H., Yoshikawa T., Yoshikawa M., Kiyohara G., et al. Direct cell entry of gold/iron-oxide magnetic nanoparticles in adenovirus mediated gene delivery. Biomaterials 2009, 30:1809-1814.
3. De la Fuente J., Berry C.C., Riehle M.O., Curtis A.S.G. Nanoparticle targeting at cells. Langmuir 2006, 22:3286-3293.
4. Sajja H.K., East M.P., Mao H., Wang Y.A., Nie S., Yang L. Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect. Curr Drug Discov Technol 2009, 6:43-51.
5. De la Fuente J.M., Berry C.C. Tat-peptide as an efficient molecule to translocate gold nanoparticles into cell nucleus. J Bioconjug Chem 2005, 16:1176-1180.
6. Berry C.C., de la Fuente J., Mullin M., Wai Ling Chu S., Curtis A. Nuclear localisation of HIV-1 tat functionalised gold nanoparticles. IEEE TNB 2007, 6:262-269.
7. Zhang Y., Yu L.C. Microinjection as a tool of mechanical delivery. Curr Opin Biotechnol 2008, 19:506-510.
8. Aspalter M., Vyas A., Feiner J., Griffin J., Brushart T., Redett R. Modification of Schwann cell gene expression by electroporation in vivo. J Neurosci Methods 2009, 176:96-103.
9. Masotti A., Mossa G., Cametti C., Ortaggi G., Bianco A., Grosso N.D., et al. Comparison of different commercially available cationic liposome-DNA lipoplexes: parameters influencing toxicity and transfection efficiency. Colloids Surf B Biointerfaces 2008, 68:136-144.
10. Sakamoto N., Tanabe Y., Yokota T., Satoh K., Sekine-Osajima Y., Nakagawa M., et al. Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA. J Gastroenterol Hepatol 2008, 23:1437-1447.
11. Harush-Frenkel O., Altschuler Y., Benita S. Nanoparticle-cell interactions: drug delivery implications. Crit Rev Ther Drug Carrier Syst 2008, 25:485-544.
12. Zhang K., Fang H., Chen Z., Taylor J.S., Wooley K.L. Shape effects of nanoparticles conjugated with cell-penetrating peptides (HIV Tat PTD) on CHO cell uptake. Bioconjug Chem 2008, 19:1880-1887.
13. Frankel A.D., Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988, 55:1189-1193.
14. Green M., Lowenstein P. Autonomous functional domains of chemically synthesised human immunodeficiency virus tat transactivator protein. Cell 1988, 55:1179-1188.
15. Derossi D., Calvet S., Trembleau A., Brunissen A., Chassaing G., Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 1994, 269:10444-10450.
16. Elliott G., O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 1997, 88:223-233.
17. Foerg C., Merkle H.P. On the biomedical promise of cell penetrating peptides: limits versus prospects. J Pharm Sci 2008, 97:144-162.
18. Vives E. Cellular uptake of the tat peptide: an endocytosis mechanism following ionic interactions. J Mol Recognit 2003, 16:265-271.
19. Kim J.A., Lee H.J., Kang H.J., Park T.H. The targeting of endothelial progenitor cells to a specific location within a microfluidic channel using magnetic nanoparticles. Biomed Microdevices 2009, 11:287-296.
20. Bhattarai S.R., Kim S.Y., Jang K.Y., Lee K.C., Yi H.K., Lee D.Y., et al. Laboratory formulated magnetic nanoparticles for enhancement of viral gene expression in suspension cell line. J Virol Methods 2008, 147:213-218.
21. Scarberry K.E., Dickerson E.B., McDonald J.F., Zhang Z.J. Magnetic nanoparticle-peptide conjugates for in vitro and in vivo targeting and extraction of cancer cells. J Am Chem Soc 2008, 130:10258-10262.
22. 4 (M=Fe, Co, Mn) nanoparticles. JACS 2004, 126:273-279.
23. Wang L., Luo J., Fan Q., Suzuki M., Suzuki I.S., Engelhard M.H., et al. Monodisperse iron oxide-gold core-shell nanoparticles. J Phys Chem B 2005, 109:21593-21601.
24. Barrientos A.G., de la Fuente M., Rojas T.C., Fernández A., Penadés S. Gold glyconanoparticles: synthetic polyvalent ligands mimicking glycocalyx-like surfaces as tools for glycobiological studies. Chem Eur 2003, 9:1909-1921.
25. Furlani E.P. Analysis of particle transport in a magnetophoretic microsystem. J Appl Phys 2006, 99:024912.
26. Furlani E.P., Ng K.C. Analytical model of magnetic nanoparticle transport and capture in the microvasculature. Phys Rev E 2006, 73:061919.
27. Furlani E.P., Ng K.C. Nanoscale magnetic biotransport with application to magnetofection. Phys Rev E 2008, 77:061914.
28. Dalby M.J., Riehle M.O., Sutherland D.S., Agheli H., Curtis A.S.G. Morphological and microarray analysis of human fibroblasts cultured on nanocolumns produced by colloidal lithography. Eur Cell Mater 2005, 9:1-8.
29. Dalby M.J., Riehle M.O., Yarwood S.J., Wilkinson C.D., Curtis A.S.G. Nucleus alignment and cell signalling in fibroblasts: response to a micro-grooved topography. Exp Cell Res 2003, 284:274-282.
30. da Costa S.R., Okamoto C.T., Hamm-Alvarez S.F. Actin microfilaments et al. - the many components, effectors and regulators of epithelial cell endocytosis. Ad Drug Del Rev 2003, 55:1359-1383.
31. Apodaca G. Endocytic traffic in polarized epithelial cells: role of the actin and microtubule cytoskeleton. Traffic 2001, 2:149-159.
32. Bareford L.M., Swaan P.W. Endocytic mechanisms for targetted drug delivery. Ad Drug Del Rev 2007, 59:748-758.
33. Luhmann T., Rimann M. Cellular uptake and intracellular pathways of PLL-g-PEG-DNA nanoparticles. Bioconjug Chem 2008, 19:1907-1916.
34. Shi W., Wang J., Fan X., Gao H. Size and shape effects on diffusion and adsorption of colloidal particles near a partially adsorbing sphere: implications for uptake of nanoparticles in animal cells. Phy Rev E 2008, 78:061914. 1-11.
35. Richard J.P., Melikov K., Vives E., Ramos C., Vebeure B., Gait M.J., et al. Cell-penetrating peptides. A reevaluation on the mechanism of cellular uptake. J Biol Chem 2003, 278:585-590.
36. Lundberg M., Johansson M. Positively charged DNA-binding proteins cause apparent cell membrane translocation. Biochem Biophy Res Commun 2002, 291:367-371.
37. Duchardt F., Fotin-Mleczek M., Schwarz H., Fischer R., Brock R. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 2007, 8:848-866.
38. Loubery S., Wilhelm C., Harbain I., Neveu S., Laouvard D., Coudrier E. Different microtubule motors move early and late endocytic compartments. Traffic 2008, 9:492-509.
39. Hillaireau H., Couvreue P. Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci 2009, 66:2873-2896.
40. Chithrani B.D., Chan W.C.W. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nanoletters 2007, 7:1542-1550.
41. Murayama M. Orientation of sickled erythrocytes in a magnetic field. Nature 1965, 206:420-422.
42. Kotani H., Kawaguchi H., Shimoaka T., Iwasaka M., Ueno S., Ozawa H., et al. Strong static magnetic field stimulates bone formation to a definite orientation in vitro and in vivo. J Bone Mine Res 2002, 171:814-821.
43. Miyakoshi J. Effects of static magnetic fields at the cellular level. Prog Biophy Mol Biol 2005, 87:213-223.
44. Coletti D., Teodori L. Static magnetic fields enhance skeletal muscle differentiation in vitro by improving myoblast alignment. Cytometry Part A 2007, 71A:846-856.
45. Pacini S., Gulisano M. Effects of 0.2 T static magnetic field on human skin fibroblasts. Cancer Detect Prevent 2003, 27:327-332.
46. Euguchi Y., Ogiue-Ikeda M. Control of orientation of rat Schwann cells using an 8 T static magnetic field. Neurosci Lett 2003, 351:130-132.
47. Higashi T., Yamagishi A. Orientation of erythrocytes in a strong magnetic field. Blood 1993, 82:1328-1334.
48. Dini L., Abbro L. Bioeffects of moderate-intensity static magnetic fields on cell cultures. Micron 2005, 36:195-217.
49. Hirose H., Nakahara T., Zhang Q.M., Yonei S., Mikakoshi J. Static magnetic field with a strong magnetic field gradient (41.7 T/m) induces C-Jun expression in HL-60 cells. In Vitro Cell Dev Biol 2003, 39:348-352.